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the relevant target sites, i.e., the outer eye, nasal cavity, and 
larynx/pharynx in humans. Special emphasis is placed on 
sensory innervation, species differences between humans 
and rodents, and possible effects of obnoxious odor in 
humans. Based on this physiological basis, Part 2 describes 
a conceptual model for the causation of adverse health 
effects at these targets that is composed of two pathways. 
The first, “sensory irritation” pathway is initiated by the 
interaction of local irritants with receptors of the nervous 
system (e.g., trigeminal nerve endings) and a downstream 
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cascade of reflexes and defense mechanisms (e.g., eye-
blinks, coughing). While the first stages of this pathway 
are thought to be completely reversible, high or prolonged 
exposure can lead to neurogenic inflammation and subse-
quently tissue damage. The second, “tissue irritation” path-
way starts with the interaction of the local irritant with the 
epithelial cell layers of the eyes and the uRT. Adaptive 
changes are the first response on that pathway followed by 
inflammation and irreversible damages. Regardless of these 
initial steps, at high concentrations and prolonged expo-
sures, the two pathways converge to the adverse effect of 
morphologically and biochemically ascertainable changes. 
experimental exposure studies with human volunteers pro-
vide the empirical basis for effects along the sensory irri-
tation pathway and thus, “sensory NOAechuman” can be 
derived. In contrast, inhalation studies with rodents inves-
tigate the second pathway that yields an “irritative NOAe-
canimal.” usually the data for both pathways is not available 
and extrapolation across species is necessary. Part 3 com-
prises an empirical approach for the derivation of a default 
factor for interspecies differences. Therefore, from those 
substances under discussion in german scientific and regu-
latory bodies, 19 substances were identified known to be 
human irritants with available human and animal data. The 
evaluation started with three substances: ethyl acrylate, for-
maldehyde, and methyl methacrylate. For these substances, 
appropriate chronic animal and a controlled human expo-
sure studies were available. The comparison of the sensory 
NOAechuman with the irritative NOAecanimal (chronic) 
resulted in an interspecies extrapolation factor (ieF) of 3 
for extrapolating animal data concerning local sensory 
irritating effects. The adequacy of this ieF was confirmed 
by its application to additional substances with lower data 
density (acetaldehyde, ammonia, n-butyl acetate, hydrogen 
sulfide, and 2-ethylhexanol). Thus, extrapolating from ani-
mal studies, an ieF of 3 should be applied for local sensory 
irritants without reliable human data, unless individual data 
argue for a substance-specific approach.
Keywords local irritants · chemosensory perception · 
Regulatory toxicology · Interspecies extrapolation
Scope
compiling toxicological profiles for chemicals in the work-
place demonstrate that sensory irritation often appears to 
be a very sensitive and relevant end point in human risk 
assessment. Accordingly, 40 % of the occupational expo-
sure limit values (Oels) are based on the avoidance of sen-
sory irritation (Dick and Ahlers 1998; edling and lundberg 
2000; van Thriel et al. 2006b). This end point is related to 
the interaction of volatile chemicals with neuronal sensors 
located in mucous membranes of the respiratory tract (RT) 
and the eyes. In many cases, data from controlled human 
studies are either not available or inadequate, so Oels are 
predominantly derived from animal data investigating local 
effects in the RT. These effects are usually measured as tis-
sue irritation. Taking these different end points (sensory 
vs. tissue irritation) and the intra- and interspecies differ-
ences into consideration, the application of default factors 
is required to establish an Oel based on animal data. This 
overview provides a process-oriented proposal for the deri-
vation of threshold limit values for substances causing local 
effects that was developed by a Joint Working group of the 
MAK commission of the german Research Foundation 
(DFg) and the Subcommittee III of the committee for Haz-
ardous Substances (AgS) of the Federal Ministry of labor 
and Social Affairs. The present paper will exclusively focus 
on substances/substance classes for which sensory or tissue 
irritation of the eyes and/or of the upper respiratory tract 
(uRT) (i.e., nose, pharynx, and larynx) has been identified 
as the most sensitive end points. Oel setting for substances 
exerting their most sensitive adverse effect in the lower res-
piratory tract (lRT) is accomplished according to the usual 
proceedings by using standard default factors.
Within this conceptual framework, it is mandatory that 
human data will not be used without considering ani-
mal data (a) to form a full picture of the mode of actions 
and (b) to take into account the thresholds of the relevant 
effects observed in the lRT of animals. even if there are 
indications that a chemical might cause sensory irritation, 
the Oel setting process still requires a full review of all 
available toxicity data of the substance in question. In a 
“case-by-case” approach, all relevant information from 
human, animal, and other experimental studies as well as 
background data are collected. Subsequently, the adverse 
effect(s) considered being crucial for the setting of an Oel 
is/are established. In addition, the physicochemical proper-
ties (e.g., water solubility, reactivity, electrophilicity) of a 
compound can provide information regarding local effects 
at the various target sites of the upper or lRT.
The present paper provides a brief description of the 
physiology of the relevant target sites, a conceptual model 
of the two modes of action underlying local effects in the 
uRT and the eyes, and finally an empirical approach, based 
on well-studied model compounds, for the derivation of a 
default factor for interspecies differences.
According to the proposed model, a “sensory NOAe-
chuman” can be derived from reflexes and defense mecha-
nisms caused by stimulation of peripheral nerves (e.g., 
trigeminal nerve endings) that can be measured distortion 
free by means of physiological parameters (e.g., eyeblink 
frequency). These effects are based on neuronal activation 
and do not represent adverse end points per se. However, 
if these sensory-mediated defense mechanisms/reflexes are 
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elicited continuously under conditions of higher or pro-
longed exposure that impede reversibility, they can finally 
result in adverse health effects (see Fig. 3b). Hence, if an 
Oel for sensory irritation is derived from such a solid, 
sensory NOAechuman and interindividual variation can be 
taken into account statically (e.g., by applying a bench-
mark dose calculation of the BMcl), a general intraspecies 
default factor must not be adopted for Oel setting.
Part 1: Local effects of irritants on the upper 
respiratory tract and the mucous membranes of the 
eyes in the working environment—basic physiological 
principles and a glossary of terminology
Introduction
A standard textbook in toxicology provides the follow-
ing distinction between systemic and local effects: “local 
effects refer to those that occur at the site of first contact 
between the biological system and the toxicant” (Klaassen 
2008).
In the working environment, chemicals can be present in 
the vapor phase but also as aerosols (i.e., liquid droplets in 
a gas), and thus, inhalation is the major route of exposure 
for many compounds. consequently, for the quantitative 
risk assessment of workplace chemicals, it can be assumed 
that the dominant effects caused by locally acting chemi-
cals are biochemical and morphological alterations of the 
RT. Moreover, chemicals can interact with the ocular sur-
face, composed of cornea and conjunctiva that is covered 
by the tear film. Regardless of active inhalation or pas-
sive diffusion, chemicals can also stimulate the sensory 
sentinels located in the RT (e.g., olfaction or trigeminal 
chemoreception in the nasal cavity) and on the ocular sur-
face and, at higher concentrations, may elicit reflexes and 
immunological defense mechanisms.
The physicochemical properties of a chemical such 
as molecular size and structure, volatility, water solubil-
ity, reactivity, and lipophilicity (i.e., logPow) determine to 
a large extent the route of exposure (e.g., inhalation), the 
target site (e.g., upper or lRT), and the transport into aque-
ous biofluids (e.g., nasal mucous, tear film) and across lipid 
membranes. For instance, lipophilic or surface-active lipo-
philic compounds may cause a destabilization of the eye 
tear film leading to epithelial damage of the conjunctiva 
(Wolkoff et al. 2003).
Aerosols are deposited in the RT according to their aero-
dynamic diameter. Aerosols with a mass median aerody-
namic diameter (MMAD) below ca. 100 µm can be inhaled, 
aerosols below 10 µm can enter the smaller airways, and 
aerosols with an MMAD below ca. 4 µm can reach the 
alveoli (ceN 1993).
The following sections describe the physiological prop-
erties of the various compartments of the RT and the eyes, 
as well as their sensory innervation.
Morphology and physiology of the target sites
Roughly, the RT can be divided into the upper (uRT) and 
the lRT. The uRT consists of nose, pharynx, and larynx. 
All segments below the trachea are considered to com-
pose the lRT. In detail, these are bronchi, bronchioles, 
and alveoli. Mucosal membranes of different morphology 
and histology cover the entire uRT as well as bronchi and 
bronchioles. The lung epithelial lining fluid (elF), also 
called surfactant, a watery layer containing a complex mix-
ture of proteins, phospholipids and fatty acids, protects the 
Fig. 1  Association between 
water solubility and pre-
dominate effect site of volatile 
chemicals (cited from Shuster-
man et al. 2003)
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alveoli (Shelley et al. 1984; Wright and clementis 1987; 
gharib et al. 2010). The elF prevents alveolar collapse 
and preserves bronchiolar patency during respiration and 
is involved in the protection of the lung from injuries and 
infection (griese 1999). During inhalation, volatile chemi-
cals are actively transported to these various compartments 
of the RT. The ocular surface is continuously exposed to 
volatile chemicals and diffusion into the tear film covering 
the outer eye causes local effects described and perceived 
as eye irritation (Wolkoff et al. 2003).
As mentioned earlier, the anatomical region within 
the RT where a particular compound preferably deposits 
is partly determined by its water solubility (Shusterman 
2003). Figure 1 illustrates this association. In addition to 
water solubility, reactivity and dosage are important fac-
tors affecting processes such as diffusion and deposition in 
the various compartments of the RT/the ocular surface. In 
humans, the ratio between nasal and oral breathing might 
also influence the first contact site of an inhaled chemical 
within the RT.
The entire RT is not “unprotected” against chemicals, 
and inhaled substance can be removed mechanically by 
means of the bronchial mucociliary escalator even from 
lower compartments of the RT (green et al. 1977). Below 
the bronchi, host defense by macrophages is becoming 
more important for local detoxification in the lRT.
Alterations within the lung/lRT may also be considered 
as local respiratory tract effects and can be accompanied by 
sensory irritation mediated via pulmonary vagal afferent 
c fibers. On the other hand, pulmonary edema, immuno-
logical effects (e.g., inflammation), or organ failure elicited 
from the disposition of xenobiotics in the lRT are severe 
and life-threatening events. As the mode of action of local 
effects in the lRT is different from that of sensory irrita-
tion in the uRT, from which it can typically not be pre-
dicted, and since these effects do not manifest immediately 
(e.g., lung edema, inflammation by particles) unlike sen-
sory effects that usually develop after a brief exposure to 
the chemical, this paper will exclusively focus on effects 
within the uRT.
Thus, the next section will cover the anatomy, physiol-
ogy, and sensory innervation of the eyes, the nasal cavity, 
and the larynx/pharynx region.
Outer eye and ocular surface
Various water-soluble chemicals (e.g., aldehydes) and 
also fine particles (e.g., sodium borate, calcium oxide) are 
known to cause eye irritation (Arts et al. 2006; lang et al. 
2008; Wolkoff and Nielsen 2010) by interacting with the 
ocular surface. Figure 2, taken from a review by Wolkoff 
et al. (2003), gives a macroscopic overview of the com-
partments of the eye that are in direct contact with the 
environment.
The central part of the cornea and the surrounding area 
of the sclera, both covered by the conjunctiva, constitute the 
ocular surface of the human eye. Both areas are composed 
of non-keratinized stratified squamous epithelium that is 
Fig. 2  Various compartments 
of the outer eye that come in 
contact with volatile chemicals, 
and the composition of the tear 
film (cited from Wolkoff et al. 
2003)
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kept moist by different glands producing the tear film. The 
tear film consists of different layers and is formed during 
the eyeblink process. Its stability is crucial for the health of 
the eyes. chronic dryness of the ocular surface resulting in 
inflammation is a cardinal symptom of Sjögren’s syndrome 
(Baudouin 2001), a systemic autoimmune disease affecting 
exocrine glands that produce tears and saliva.
Any thinning of the tear film destabilizes this protective 
layer, and its rupture shortens the breakup time (BuT) of 
the tear film. The BuT can be measured as the time inter-
val from the last complete eyeblink until the occurrence of 
dry spots on the ocular surface. usually, this BuT is within 
the time interval between two consecutive blinks (3–5 s) 
resulting in a normal blink frequency of 12–20 blinks/min 
(for more details see Wolkoff et al. 2003). Any reduction 
of the BuT, for instance by exposure to a chemical, needs 
to be counteracted by an “extra eyeblink.” Thus, the BuT 
is negatively correlated with the blink frequency. However, 
not the rupture of the tear film itself but the preceding sen-
sation via the trigeminal nerve causes this blinking reflex. 
The ophthalmic (V1) branch of the trigeminal nerve inner-
vates the conjunctiva and cornea of the eye, and the ocular 
surface is one of the most densely innervated structures of 
the body (Beuerman and Stern 2005; Veiga Moreira et al. 
2007). Veiga Moreira et al. (2007) showed by means of 
retrograde tracing and electrophysiological techniques 
that both neurons from myelinated Aδ and unmyelinated 
c fibers receive input from the ocular surface. In accord-
ance with intranasal trigeminal functions in humans, eye 
irritations are perceived as stinging and burning sensations 
(Hummel 2000). Such “eye symptoms” are often used in 
questionnaires assessing eye complaints related to envi-
ronmental hazards (Franck and Skov 1991). However, 
prolonged stimulation of trigeminal receptors located on 
the ocular surface might cause neurogenic inflammation, a 
defense mechanism that is thought to be “the first line of 
defense for the ocular surface” (Beuerman and Stern 2005). 
The release of neuropeptides such as substance P or cal-
citonin gene-related peptide (cgRP) leads to a breakdown 
of the blood-tissue barrier facilitating the infiltration of 
immune cells like polymorphonuclear leukocytes into the 
tears (Beuerman and Stern 2005). Thus, overstimulation 
of the chemosensory system of the outer eye might be the 
starting point for inflammation and tissue damage. Such 
damage can be found in ocular surface diseases (OSNs, 
e.g., the hallmark in Sjögren’s syndrome) that are associ-
ated with loss of health-related quality of life and should be 
regarded as a severe health problem (Baudouin et al. 2008).
In regulatory toxicology, eye irritation after direct con-
tact is an important end point for the classification of chem-
icals. Historically, the Draize test in rabbits has been used 
to investigate this aspect of acute toxicity. even though the 
physiology of the human ocular surface is different from 
that of rabbits, eye irritation thresholds in humans and 
Draize test scores might be based on a similar mode of 
action (Abraham et al. 2003). However, the human eye is 
regarded as less sensitive than the rabbit eye (Barile 2010) 
so that the results of the eye irritation test in rabbits tend to 
overpredict the risk for humans. More recently, alternative 
methods have been developed and validated as screening 
tests for severe eye irritants and corrosive materials (e.g., 
bovine corneal opacity and permeability test, BcOP; iso-
lated chicken eye test, Ice; Barile 2010) including in vitro 
models using chemical-sensing ion channels like the tran-
sient receptor potential vanilloid type 1 (TRPV1) receptor 
(lilja and Forsby 2004; lilja et al. 2007), but little experi-
ence has been gathered in routine testing of such methods 
so far. These tests give a measure of the severity of sen-
sory irritation effects of chemicals on the eye, and Draize 
test scores have been shown to be in good agreement with 
human eye irritation thresholds (Abraham et al. 2003). 
eye irritation thresholds and nasal pungency thresholds as 
a measure of sensory irritation were found to correspond 
closely to each other in humans (cometto-Muñiz and cain 
1995). Therefore, the eye irritation potency is also regarded 
as predictive for the potency of irritation effects in the uRT. 
There is not always a consistent correlation between Draize 
test scores and potency in sensory irritation tests, like the 
RD50 bioassay (ciuchta and Dodd 1978), but empirically, 
substances classified as irritating to the eye based on the 
Draize rabbit eye test can reasonably be expected to act as 
local irritants in the uRT, too. As alternatives to the Draize 
test, the BcOP test (OecD Test guideline 437), the Ice 
test (OecD Test guideline 438), and the Fluorescein leak-
age test (Tg 460) have found acceptance in regulatory toxi-
cology. The acceptance of these tests is based on their capa-
bility to predict eye irritation with high severity and even 
corrosion, used to characterize classification category 1 of 
eye effects in globally harmonized system (gHS). Insofar, 
a positive test result in one of the alternative test systems 
can be expected to be predictive for a local irritation effect 
in the uRT. However, there is no correlation between the 
scores obtained in these tests and the potency in the RD50 
bioassay.
While the human ocular surface is a relatively homog-
enous tissue, the anatomy of the nose is far more complex. 
The following chapter provides only a brief overview and 
the reader is referred to the recently published volume 
“Toxicity of the nose and the upper airways” (Morris 
and Shusterman 2010) of the book series on target organ 
toxicity.
The nasal cavity
The nose is the primary entry for inhaled air and is 
divided into two air passages separated by the nasal 
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septum. While many rodent species are obligate nose 
breathers, humans can switch between nasal and oral 
breathing. The nasal-to-total ventilation rate is mark-
edly reduced especially during exercise, and at moderate 
workload levels [in females at approximately 20 % of the 
maximal physical work capacity (PWcmax); in males at 
approximately 40 % PWcmax, corresponding to 22–23.5 l/
min or 10 m3/8 h, the default ventilation rate assumed in 
the setting of Oels], the nasal contribution is reduced to 
79 and 67 %, respectively (Bennett et al. 2003). Neverthe-
less, a great proportion of the total ventilation will pass 
the different epithelia of the nasal cavity even in situa-
tions with moderate workload.
The nasal passage extends from the nostrils to the naso-
pharynx and the nose functions as a “scrubbing tower” for 
the lower compartments of the RT. Due to physiological 
(e.g., cellular composition of the respiratory epithelium) 
and anatomical features (e.g., turbinates), the nose filters, 
warms, and humidifies the inhaled air and also effectively 
absorbs water-soluble volatile chemicals, traps inhaled par-
ticles, and metabolizes airborne xenobiotics. In general, 
two different epithelia can be found in the nasal cavity. The 
respiratory and olfactory epithelia cover different regions 
of the medial and lateral walls of the nasal cavity, and serve 
different functions, and thus, their cellular architecture and 
molecular functionality are also diverse.
The respiratory epithelium (RE)
The cellular composition of the epithelium gradually 
changes from the nasal valve to the posterior parts of the 
nasal vault. Squamous epithelium without microvilli covers 
the intranasal walls of the anterior part. The anterior tips of 
the turbinates provide the transition from the squamous to 
transitional and finally to pseudostratified columnar ciliated 
epithelium, lining the remaining parts of the nasal cavity 
except the roof, which is covered with the olfactory epithe-
lium (Oe).
The majority of cells composing the Re are of three 
types: basal cells, goblet cells, and columnar cells which 
are either ciliated or not. Basal cells have some ability to 
differentiate into other cells types, i.e., their function is 
associated with repair and regeneration of the Re after any 
kind of tissue damage. goblet cells produce secretions that 
contribute to the mucous blanket. The major function of 
the ciliated cells is moving up the mucus to the pharynx, 
except in the region anterior to the inferior turbinate, where 
transport is anterior. The non-ciliated cells are thought 
to exhibit high metabolic activity, as they are rich in 
cytochrome P450 enzymes and esterases. Since most of the 
knowledge about the metabolizing capacity of the nose has 
been derived from rodent studies, some pronounced species 
differences have to be considered in the species-to-species 
extrapolation. In contrast to the human Re, the rat Re addi-
tionally contains brush cells supposed to have a neurologi-
cal and sensory function. Furthermore, the goblet and the 
non-ciliated cells in the transitional epithelium contain 
abundant smooth endoplasmic reticulum (Harkema et al. 
2006), suggesting that these cells may have metabolic 
capacities for certain xenobiotic-metabolizing enzymes 
(e.g., cytochrome P450 enzymes, carboxylesterases, alde-
hyde dehydrogenases, epoxide hydrolases, and glutathione 
S-transferases). Therefore, the metabolic capacity might be 
higher in the rat than in the human nose (for details, see 
chapter 5 in Morris and Shusterman 2010).
like the tear film covering the ocular surface, the mucus 
blanket covers the Re. It is composed of a lower, serous sol 
layer in which the cilia beat and a viscoelastic or gel layer 
is located above the cilia. The nasal mucous fluid is pro-
duced constantly by the various glands and is moved from 
the nasal cavity through the nasopharynx into the pharynx 
and then swallowed via the esophagus. The cilia beat in a 
fixed direction in a two-stroke pattern: an effector stroke, in 
which the cilia straighten, contact the gel layer, and moves 
the mucus; and a recovery stroke, in which the cilia bend 
and move in the watery sol layer.
This system is known as mucociliary clearance and 
serves important protective functions: It clears the nasal 
cavity of secretions and trapped particulates, provides water 
for humidification, and is known to exhibit a strong anti-
oxidant activity. Furthermore, it is the first line of defense 
against bacterial and viral infection, as components of the 
mucus include IgA, Igg, Ige, histamine, albumin, lacto-
ferrin, lysozyme, and cellular debris (Sahin-yilmaz and 
Naclerio 2011). Mucociliary clearance rates of 3–25 mm/
min have been shown in healthy humans (Mygind and Dahl 
1998). Thus, normal mucociliary transit time takes between 
12 and 15 min (Andersen and Proctor 1983). Transit times 
of more than 30 min are considered to be abnormal and 
are indicative of an impaired mucociliary clearance. In 
humans, mucociliary clearance can be assessed by the sac-
charine test (Muttray et al. 2002).
In the nose of rats, mucociliary clearance velocities 
of 1.1–5.9 mm/min were measured (Krinke 1999). even 
though the speed of cilia-driven transportation is higher in 
humans than in rats, the transportation distance is longer, 
too.
The sites of certain toxicant-induced nasal injuries 
also differ between rats and humans because of intranasal 
regional differences in the amount of neutral and acidic 
mucosubstances. In humans, an increasing anterior-poste-
rior gradient can be found with higher amounts in the distal 
nasopharynx area than in the anterior nasal airway. In con-
trast, the rat produces considerably more of these mucosub-
stances in the anterior septal region than in the nasophar-
ynx area (Harkema et al. 2006).
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Sensory innervation
The Re in the nasal cavity is innervated by the trigemi-
nal nerve. Humans are aware of the stimulation of the free 
nerve endings/receptors by feeling sensations like burning, 
stinging, warmth, coolness, or itching (Hummel 2000). 
The signal transduction is predominantly mediated via 
multimodal ion channels (e.g., transient receptor poten-
tial ion channels like TRPV 1–4) that can be activated by 
temperature, irritants (chemicals), pH changes, or endog-
enous inflammatory mediators (Story 2006). These chem-
ical-sensing receptors are not exclusively expressed in the 
trigeminal nerve. The whole somatosensory system of the 
peripheral nerves strongly depends on TRP channels. There 
are 28 TRP channels in mammals, detecting endogenous 
and environmental stimuli, such as temperature, mechani-
cal forces, chemical stimuli, and pain (Vandewauw et al. 
2013). These authors showed in their recent comparison of 
dorsal root ganglia (DRg) and trigeminal ganglia (Tg) of 
mice that only the mRNA of TRPc1, TRPM4, TRPM8, and 
TRPV1 was differently expressed in the various ganglia.
Afferent fibers of the trigeminal nerve also supply the 
mucous membranes of the eyes, oral cavity, and nasophar-
ynx. This chemical sense has been termed “chemo-soma-
tosensation,” “chemesthesis,” or “common chemical sense.” 
Recently, Shusterman and Hummel (2009) proposed the 
more neutral terminology “trigeminal chemoreception” for 
all feelings associated with the stimulation of cranial nerve 
V (Shusterman and Hummel 2009). Trigeminal chemore-
ception is considered the most important sensory pathway 
in the context of sensory irritation (see Part B of the manu-
script). Various reflexes (e.g., sneezing) and defense mech-
anism (e.g., neurogenic inflammation) are associated with 
the stimulation of free nerve ending of the trigeminal nerve 
in the nasal cavity.
The olfactory system
At the very top of the nasal cavity, beneath the cribriform 
plate of the ethmoid bone, a small area of the human nasal 
cavity (approximately 500 mm2) is covered by the Oe. In 
humans, the Oe occupies approximately 3 % of the nasal 
cavity, while in rats this tissue covers 50 % of the intrana-
sal surface and extends also to more anterior parts of the 
nasal cavity. The Oe is mainly composed of three epithe-
lial cell types: the olfactory sensory neurons (OSNs), the 
supporting (sustentacular) cells, and the basal cells. The 
Oe is one of the rare cNS structures where adult neuro-
genesis has been confirmed. OSNs undergo apoptosis and 
are able to regenerate due to the capacity of progenitor 
cells in the basal cell layer of the Oe to proliferate and dif-
ferentiate into mature OSNs. Thereby, the olfactory func-
tion is maintained even though inhaled xenobiotic agents 
may have induced severe cell injury and death of OSNs. 
Several studies have suggested that inflammatory sign-
aling pathways may play a key role in the regulation of 
OSN regeneration. The baseline turnover rate has been 
proposed to lie between 28 and 30 days, yet more recent 
studies have shown that many OSNs are more long-lived 
(Harkema et al. 2006). In humans, this turnover process 
fails with age, and the surface area of the Oe as well as 
the number of olfactory receptor neurons (ORNs) declines. 
Sustentacular cells contain abundant smooth endoplas-
mic reticulum and xenobiotic-metabolizing enzymes (e.g., 
cytochrome P450 enzymes, flavin-containing monooxyge-
nases, N-acetyltransferases). They are supposed to contrib-
ute to the detoxification of inhaled xenobiotics and to play 
a role in the chemical interaction between odors and their 
olfactory receptors (ORs) by influencing the regulation of 
the ionic composition of the overlying mucous layer. like 
the sustentacular cells, the Bowman’s glands contain many 
xenobiotic-metabolizing enzymes. Furthermore, they con-
tain copious amounts of neutral and acidic mucosubstances 
and are solely responsible for the production and secretion 
of mucus covering the surface of the Oe.
ORNs are predominantly located in the Oe. The cilia 
of these neurons extend to the lumen and their cell mem-
branes contain the ORs. Only one type of OR is expressed 
in each ORN, and the axonal projections of similar ORNs 
converge on glomeruli located in the olfactory bulb. Thus, 
the ORNs are neuronal structures that are in direct contact 
with all sorts of contaminants of the inhaled air (e.g., bac-
teria, viruses, volatile chemicals). Approximately 1,000 
genes and pseudogenes encoding about 350 different and 
functional ORs are known in humans (Mombaerts 2001) 
and with this repertoire of odorant-specific receptors “we 
can detect hundreds of thousands, if not millions, of dis-
tinct odors” (Mombaerts 2001, p. 493). However, one has 
to bear in mind, that during normal breathing only 15 % 
(measured in rats; corresponding to 7 % in humans) of the 
inhaled air reach the Oe (Kelly et al. 2000) via the dor-
sal medial airflow pathway, while a larger proportion just 
passes the Re via the lateral/ventral airflow pathway (Mor-
ris et al. 1993). Because of this, segmentation the Oe of 
humans is more protected from exposure to chemicals than 
the respiratory epithelium. However, the sensitivity of the 
olfactory system is enormous, and for some chemicals such 
as skatole/3-methylindole, as few as 10 molecules might 
be sufficient to trigger an action potential at the receptor 
level and the subsequent detection of the odor by the cen-
tral nervous system (Hatt 2000). This sensitivity is partly 
achieved by actively sniffing the odorants and increasing 
the airflow of the dorsal medial airflow pathway (Kareken 
et al. 2004; Sobel et al. 2000).
As pointed out previously, for the majority of vola-
tile chemicals the olfactory system is more sensitive than 
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trigeminal chemoreception (Shusterman 2001). This 
assumption has been confirmed for various irritants used in 
working environments as shown by comparing the respec-
tive odor and lateralization thresholds (van Thriel et al. 
2006a).
larynx/pharynx
A mixture of afferent fibers from the glossopharyngeal 
nerve and the vagus nerve mainly innervate pharynx and 
larynx. Particularly, the superior part of the pharynx and 
parts of the oral cavity are solely innervated by the glos-
sopharyngeal nerve. On the contrary, the inferior part of the 
larynx is exclusively innervated by the vagus nerve. Addi-
tional receptors are scattered in the airway walls within 
these compartments of the uRT, and the surrounding mus-
cles become more important. In the pharynx, a sniff-like 
aspiration reflex mediated by receptors in the squamous 
cell epithelium of this region protects lower compartments 
of the RT. Receptors in the larynx that respond to changes 
in osmolality are important in mediating swallowing. Nev-
ertheless, multimodal receptors responding to chemical 
and mechanical stimuli (pain receptors), comparable to the 
intranasal receptors, also contribute to the manifold reflexes 
(e.g., by increasing mucus secretion or causing cough) 
that can be elicited by sensory nerves in these parts of the 
uRT (Widdicombe 1982). The TRP channels (especially 
TRPV1) of this sensory pathway are mainly involved in 
coughing, a defense mechanism of the airways that is sup-
posedly associated with sensory hyperreactivity (Millqvist 
2000). From a physiological/biological point of view, these 
sensory-mediated airway reflexes, but also the intranasal 
reflexes like sneezing, nasal blockage (airflow obstruction), 
secretion (with or without associated inflammation), and 
mucociliary clearance, are important defense mechanisms 
protecting the lower parts of the RT, especially the alveoli, 
from harmful effects.
As in the case of the nose and other mucosal surfaces, 
the most rostral areas of the larynx lined by stratified 
squamous epithelial cells are those that are most directly 
exposed to inhaled substances. The thickness of the epithe-
lium and the inherent resistance to damage of its squamous 
surface layers provide more protection than other types of 
epithelia. Nevertheless, the stratified squamous epithelium 
lining the rostral larynx of rodents is still more susceptible 
than that in other areas of the oropharyngeal cavity because 
it lacks keratin or is poorly keratinized under normal con-
ditions compared to oral or nasal mucosa under normal 
conditions. Thus, exposure to irritants can induce edema, 
inflammation and, if prolonged and severe enough, blis-
tering, necrosis, and epithelial sloughing. The epithelium 
lining the base of the epiglottis where the transition from 
stratified squamous epithelium to Re occurs in rodents is 
the area of the laryngeal epithelium that is most suscepti-
ble to damage from inhaled materials. The normal mucosal 
epithelium at the base of the rodent epiglottis consists of 
two to three layers of a mixture of ciliated and non-ciliated 
columnar cells, with no definite basal cell layer. A small 
area in the ventral midline at the rostral and caudal borders 
of the submucosal glands may be covered by squamous 
epithelium, but these areas do not have the prominent basal 
cell layer typical of stratified squamous epithelium (Renne 
and gideon 2006).
Biological relevance of the trigeminal and olfactory system
The trigeminal system is involved in pain sensation, and 
various nociceptors are expressed intranasally (Julius and 
Basbaum 2001). Pain is a useful warning system in all spe-
cies and the sensation of pain triggers appropriate protec-
tive responses, mainly achieved via reflexes, as described 
previously. Thus, the response patterns are similar within 
and across species, resulting in a low inter- and intraspecies 
variability with respect to the biological significance of the 
sensory input. One approach to determine the activation of 
trigeminal chemoreceptors in the nasal cavity across spe-
cies is to measure of the negative mucosa potential (NMP, 
Kobal 1985). The NMPs, elicited by 45 or 60 % of cO2, 
increased in rats by approximately 50 % (Thürauf et al. 
1991). In humans, a comparable increase in cO2 resulted 
in an almost identical increase of the NMP (Hummel et al. 
1998). Particularly, the higher cO2 concentration was per-
ceived as painful (Hummel et al. 1998), revealing the bio-
logical relevance of trigeminal chemoreception. However, 
such perceptional aspects of trigeminal chemoreception are 
not assessed in inhalational exposure studies in rodents, but 
the NMPs, the electrophysiological correlates, can be used 
as comparable measures.
The functional role of the olfactory system in humans 
is less clear. Three categories of function related to inges-
tion, avoidance of environmental hazards, and social com-
munication have recently been described (Stevenson 2010). 
Because of this broad functional spectrum, it is obvious 
that a large variety of differently concentrated odors have 
to be detected by the olfactory system. Moreover, there is 
no conclusive evidence, at least in humans, that the afore-
mentioned categories of function are accomplished via 
reflexes of the olfactory system. Thus, learned response 
patterns (e.g., established via classical conditioning) might 
trigger “automated” responses (e.g., food avoidance) to cer-
tain odorants. compared to the more uniform, trigeminal-
mediated “pain” response, odors are capable to provoke a 
variety of behavior associated with the avoidance of envi-
ronmental hazards (e.g., involuntary attention shift toward 
the odor/odor source). When sensory irritation effects are 
assessed for deriving exposure limits, the avoidance of 
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excessive annoyance due to obnoxious odors might serve 
as basis for setting an Oel (e.g., DFg MAK list).
Odor effects in humans
In animal studies, odor effects are usually not explored 
even though odor avoidance behavior is used as readout 
in neurobehavioral tests (cloutier et al. 2006). Therefore, 
odor effects are usually investigated in human volunteer 
studies and subjective reports (e.g., ratings of odor inten-
sity and quality) are the major source of information. Such 
information is subjected to various non-sensory factors 
(e.g., personality, pre-experiences with and/or information 
about the chemical), as shown repeatedly in chemosensory 
research (Dalton 1996, 1999, 2002, 2004). Thus, the use of 
such data in toxicological risk assessment is tricky. Never-
theless, odor annoyance should be defined in the context of 
this paper. Based on the general definition in the framework 
of quantitative risk assessment, a definition could read like 
odor annoyance is a feeling of displeasure associated with 
any agent or condition identifiable by the olfactory system 
that is believed by the person to affect adversely an indi-
vidual or a group (Koelega 1987).
The critical aspect of this definition is the phrasing … 
believed to affect adversely … that pinpoints to the implicit 
shortcoming that there is no objective or physiological/bio-
logical marker of adverse odor effects. There is no reflex 
based on the stimulation of olfactory receptors, and thus, 
physiological readouts comparable to those of the three 
other cranial nerves innervating the RT are not available. In 
some recent papers (Kleinbeck et al. 2008; Hey et al. 2009; 
Rohlman et al. 2008), the use of neurobehavioral methods 
has been proposed to assess adverse effects of odors in the 
working environment. However, a general evaluation of 
this approach is still lacking.
Species differences
Physiological factors
In human risk assessment, laboratory animal studies are 
the major source of evidence especially when evaluating 
health effects of chronic exposures. That is also true for 
local effects in the uRT. In case of interspecies extrapo-
lations, differences in anatomy, physiology, and breath-
ing patterns have to be considered because they determine 
the dose delivered to the target site (carey et al. 2007). 
Some interspecies differences with respect to anatomy 
and physiology have already been described in previous 
sections (e.g., size of the Oe; distribution of squamous, 
transitional, and respiratory epithelium), but interspe-
cies differences related to airflow dynamics have not been 
addressed so far. The distribution of airborne toxic agents 
within the nasal cavity is of special interest since differ-
ent airflow velocities caused by anatomical features like 
the three turbinates largely affect both the deposition and 
the chemosensory perception of inhaled chemicals (Kelly 
et al. 2000). In humans, these structures are relatively sim-
ple in shape compared to the rodent nasal turbinates that 
have complex folding and branching patterns. In addi-
tion, the types and distribution of nasal surface epithelia 
differ among species (Harkema 1991). Models of human 
and rat nose have shown that the air stream over the human 
olfactory epithelia amounts to only 50 % of that of the rat 
(Frederick et al. 1998). This would be an argument in favor 
of a reduced variability factor for substances acting on the 
olfactory mucosa. Because of these anatomical character-
istics of the rodent and the human nose and their effects on 
airflow and deposition, the extrapolation from rodents to 
humans should be based on fluid dynamics models to esti-
mate the local concentrations of the compound (Schroeter 
et al. 2006; Kimbell et al. 1993). These models are avail-
able for several compounds (corley et al. 2012; Schroeter 
et al. 2006; Sweeney et al. 2004), but due to physicochem-
ical differences affecting the preference for a specific epi-
thelium type (e.g., olfactory or respiratory; garcia et al. 
2009), general conclusions about species differences are 
difficult to draw.
Intranasal toxification and detoxification
As mentioned in one of the previous sections, nasal tissues 
have a capacity to metabolize airborne xenobiotics. local 
biotransformation can thereby profoundly influence their 
toxicity. compared to humans, the nasal tissue of rodents 
differs markedly with respect to enzymology. Particularly, 
rodents express high levels of cytochromes P450 (cyP) and 
also of other enzymes such as carboxylesterases, epoxide 
hydrolases, and acetaldehyde dehydrogenase (Ding and Dahl 
2003). In humans, cytochromes P450 enzymes have been 
detected in nasal respiratory and olfactory mucosa (Ding 
and Kaminsky 2003), but their activities are apparently 
lower than those in the respective rodent tissues. For certain 
compounds, such as beta-lactones, esterases capacities may 
exert a detoxifying activity. In such cases, the sensitivity of 
humans toward the toxic activity of the parent compound 
might be higher. However, many esters and lactones are 
quite inert as parent compounds, whereas their cleavage by 
carboxylesterases may generate carboxylic acids as a sequel 
products at the intracellular level that lead to tissue irritation. 
In those cases, humans should be less sensitive than rats. 
Acrylic esters also show (as parent compounds) a consider-
able electrophilic reactivity toward proteins and may thus be 
more irritating than the esterase-mediated cleavage products. 
Methacrylates are much less reactive toward proteins and are 
normally not sensitizing. Hence, these compounds should 
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be more similar to saturated esters than to acrylate esters in 
respect of species differences.
Methyl methacrylate is hydrolyzed to methacrylic acid 
by carboxylesterases. Inhibition of these enzymes reduced 
the severity of nasal lesions induced by this compound in 
rats, indicating that the toxic agent is methacrylic acid. 
Since the activity of carboxylesterases in humans is lower 
than that in rats, it can be assumed that tissue irritation 
occurs only at higher concentrations in man. N-butyl acetate 
is hydrolyzed to acetic acid and n-butyl alcohol. Because 
of the aforementioned species differences in enzyme activ-
ity, the metabolite acetic acid might cause tissue irritation 
at lower concentrations in rodents than in humans. The sit-
uation is different with acrylates, as the parent compound 
(e.g., ethyl acrylate, human NOAec 2.5 ppm, see Part III) is 
more irritating than the cleavage product acetic acid (human 
NOAec 10 ppm, ernstgard et al. 2006). This is due to the 
highly reactive alpha, beta-unsaturated Michael system of 
the acrylates that is more irritating than the cleavage prod-
uct, whereas the Michael system of methacrylates is known 
to be less reactive compared to that of acrylates.
Moreover, TRP channels in free nerve endings of the 
trigeminal system might only be activated by certain 
metabolites. lanosa et al. (2010) showed that sensory irri-
tation in mice induced by styrene was reduced after inhi-
bition of cyP with metyrapone (measured by a RD50-like 
paradigm) and that this effect was mediated via a specific 
TRP channel as revealed in TRPA1 −/− knockout mice. 
The same results were obtained when naphthalene was 
used to induce sensory irritation.
Taken together, these results provide evidence that sub-
stances might be metabolized to reactive intermediates by 
cyP enzymes located in the uRT. In these cases, species 
differences in cyP activity must be taken into account if 
respective data are available.
Deposition in nasal tissues
Acrylic acid has been shown to be deposited in the human 
nose to a lesser degree (52 %, Frederick et al. 1998) than in 
the nose of rats (97 %, Morris and Frederick 1995).
In contrast, according to calculations of csanády and 
Filser (2007), the concentrations of propylene oxide are 
similar in the nasal mucosa of humans and rats when both 
species are exposed to the same concentration at rest, tak-
ing into account the metabolic detoxification of this com-
pound in rat mucosa but not in human mucosa.
Selected differences in morphological and physiologi-
cal features between rats and humans are summarized in 
Table 1. The proposed reference values vary depending on 
sex, body weight, and size.
For more details, see Morris and Shusterman (2010).
These species differences will be of relevance when rec-
ommendations for human risk assessment in the working 
environment will be given (see Part 3 of the overview). In 
general, the anatomy of the uRT of rodents might be associ-
ated with a higher sensitivity for local effects in these species.
In summary, the first section of this overview summa-
rized the physiology of the uRT and the outer eye in rela-
tion to the possible target tissues of locally acting chemi-
cals. It has been highlighted that the various compartments 
of the uRT and the mucous membranes of the eyes are (a) 
richly innervated and equipped with different sensory recep-
tors and (b) possess a heterogeneous mixture of different 
types of epithelia that are composed of various cell types 
serving diverse functions (e.g., local detoxification). Thus, 
sensory and non-sensory targets may be the starting point of 
a process that, under certain circumstances, leads to adverse 
health effects both in animals and humans. In the next sec-
tion, a conceptual model of these processes will be proposed 
and definitions of the key terminology will be provided.
Part 2: Local effects of irritants on the upper 
respiratory tract and the mucous membranes 
of the eyes in the working environment—sensory 
and non‑sensory origins
A model for two modes of action
effective host defense against irritation of the uRT is based 
on a time-shared interaction of the peripheral nervous and 
Table 1  Differences in anatomy, physiology, and air flow dynamics between humans and rats
Human Rat
Morphology Three turbinates in the nasal cavity with simple shape Several turbinates with complex branching and folding patterns
Average percentage of Oe: 3 % Average percentage of Oe: 50 %
low metabolic capacity in the Re because of the lack of non-
ciliated cells in the transitional epithelium
High metabolic capacity of cells located in the Re
Physiology Nasal and oral breathing Obligate nose breathers
Pulmonary ventilation: 7.5 l/min (Arms and Travis 1988) Pulmonary ventilation for 260 g rat: 0.2 l/min (Bide et al. 2000)
Air flow over Oe: 7 % Air flow over Oe: 15 %
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the innate immune system. Both systems possess receptors 
for the detection of exogenous and endogenous hazards 
(e.g., xenobiotics, pathogens, hypoxic environment), and 
especially in the peripheral nervous system, some of these 
receptors are co-localized on afferent fibers (chiu et al. 
2012). In Fig. 3a, two pathways of local effects of irritants 
and their mutual interaction are schematically illustrated.
The first pathway (sensory irritation in Fig. 3a) is a 
receptor-based interaction of the chemical with sensory 
neurons located in the respiratory and olfactory epithelia 
and the cornea/conjunctiva. Thus, the targets are neuronal 
cells and their ramifications in the mucous membranes. 
consequently sensory irritation is a very rapid process 
that can proceed within milliseconds from stimulation to 
awareness. However, at concentrations exceeding a cer-
tain effect threshold, the stimulation of neuronal receptors 
is supposed to be also the initial step of the first mode of 
action leading to adverse health effects on the uRT and 
the eyes. In regulatory toxicology, this pathway is usually 
linked to the term sensory irritation (Shusterman and Hum-
mel 2009) caused by the repeated or strong stimulation of 
the chemosensory systems as described in Part 1 of this 
paper. Regarding dose/concentration dependency in men, 
but also in laboratory animals, sensory irritation is usually 
caused by lower concentrations, while higher concentra-
tions and prolonged high exposure (see Part 3) might pro-
duce tissue damage in the uRT (with the exception of com-
pounds with a weak or without a sensory warning effect; 
Fig. 3  a A scheme of two 
interlinked pathways relevant 
for the causation of local effects 
in the upper respiratory tract 
and the mucous membranes of 
the outer eye. b localization of 
two different NOAecs on the 
two-pathway model supposed 
to underlie local effects on the 
respiratory tract and the mucous 
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see second pathway). At low concentrations, acute effects 
such as olfactory (annoyance) or trigeminal (stinging, itch-
ing) perceptions can be considered as unpleasant sensa‑
tions, which are, however, totally reversible. In Fig. 3a, the 
adversity of the sensory-mediated effect increases from left 
to right, and the initial unpleasant sensation might become 
an adverse health effect due to the cascade of physiological 
defense mechanisms and finally tissue damage. However, 
physiological events in the first pathway can be detected 
at very low concentrations. This fact is visualized by an 
earlier start of the arrow. Furthermore, sensory irritation 
is a very fast reaction. A thin arrow visualizes this speed 
component.
The second pathway (tissue irritation in Fig. 3a) starts 
with interactions of airborne chemicals (e.g., dibutyl phtha-
late, DBP) and non-sensory targets (e.g., epithelial cells). 
In contrast to the first pathway, these targets are not exclu-
sively located on neuronal cells, and thus, all cell types 
composing the mucous membranes of the uRT and the 
eyes can be affected. Therefore, this pathway is linked to 
the term tissue irritation. “Induction of cell impairment” 
can include damage of cell membranes and cytoskeleton, 
impaired energy charge or disturbances of the cell homoeo-
stasis. It is unclear which of these effects governs inflam-
matory cell signaling. compared to the first pathway, the 
irritation process is slower, lasts minutes or rather hours 
or days, and usually starts at higher concentrations or 
with prolonged or repeated exposure. This is visualized 
in Fig. 3a by a thicker arrow and a later start. Again, the 
adversity of the effects increases along this pathway.
Moreover, the two proposed response cascades are inter-
linked (indicated by the double-headed arrows): effects 
along the tissue irritation pathways can be sensed by nocic-
eptors (e.g., TRPV1) that are also involved in the first path-
way. In parallel, effects along the sensory irritation path-
way (e.g., inflammation) might encroach on non-sensory 
epithelial cells. At a certain point in the proposed model, 
these overlaps hamper the distinction between the starting 
points of the local effect.
While the short-term stimulation of the sensory irritation 
pathway is thought to be totally reversible (Hummel 2000), 
it is considered the human lowest observable effect concen-
tration (lOec, based on physiological measures of nerve 
stimulation). Because adverse health effects do not occur at 
this concentration, the human sensory lOec can be used 
as surrogate for the no observed adverse effect concen-
tration (NOAec). Repeated exposures to concentrations 
above this NOAec resulting in prolonged nerve stimula-
tion (within hours) that might occur in working environ-
ments can trigger a response cascade leading to chronic 
adverse health effects.
Neurogenic inflammation plays an important role along 
the sensory irritation pathway (Beuerman and Stern 2005; 
lacroix and landis 2008). It reflects the transition from 
pure sensory, reversible effects (including sensory-medi-
ated reflexes like coughing, sneezing, and lacrimation) 
to more general and inflammatory defense mechanisms 
against the toxic action of xenobiotics, likewise seen along 
the tissue irritation pathway. A recent review describes 
the similarity between the molecular recognition path-
ways of nociceptor neurons with those of immune cells 
and the direct communication between these cell types in 
response to danger (chiu et al. 2012). As an immediate 
first responder (e.g., feeling the pain), the nervous system 
is equipped with neuronally released mediators (e.g., sub-
stance P) signaling to vascular endothelial cells to increase 
blood flow and vascular leakage. Moreover, sensory nerves 
are equipped with cytokine receptors (e.g., Il-1β or TNF-α 
receptors) that increase membrane excitability by intracel-
lular MAP kinases signaling. Thus, a non-sensory pathway, 
namely the release of cytokines, might facilitate an increase 
of sensory perception. In humans, these subsequent effects 
of sensory stimulation might be considered the lowest 
observed adverse effect concentration (lOAec).
In parallel, the second pathway might also start as a 
reversible, adaptive response that leads to a chronic adverse 
health effect when the physiological repair capacities 
become overwhelmed. Because of these capacity-depleting 
effects even at the initial steps of the second pathway, the 
exposure duration might be more important than in the first 
pathway where a more threshold-like mechanism indicates 
the switch from sensory to non-sensory responses/reflexes.
Regardless of the initial steps, the tissue irritation and 
the sensory irritation pathways might cause chronic effects 
like inflammation and tissue damage mediated by the 
innate and adaptive immune system (Tan et al. 2010). Both 
pathways can become indistinguishable at this final point. 
This is visualized in Fig. 3a by convergent arrows that end 
in the same box displaying the final step of both pathways.
Based on this conceptual model and in order to concep-
tualize the theoretical framework of local effects on the Re 
and the eyes, the following definitions of the key terms are 
proposed:
Sensory irritation is defined as sensory-mediated 
responses of nervous system pathways in the target site, in 
humans accompanied by trigeminal and olfactory chemore-
ception (feeling of the exposure) that can trigger a broad 
array of defense mechanisms protecting the RT and the eye. 
These primary reactions are thought to lead only to revers-
ible alterations of the physiology/biology of the target site. 
However, prolonged exposure at a concentration exceeding 
a certain effect threshold (e.g., of disturbing homeostasis 
or overpowering metabolic detoxification) might deplete 
the physiological resources for the reflex-like defense pro-
cesses, and additional responses, mainly from the immune 
system, might become important.
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Tissue irritation is defined as (a) damage of proteins, 
membranes, or organelles of the non-sensory cells in the 
respective epithelia, leading to (b) macroscopically or 
microscopically visible changes (e.g., dry spots, redness) 
at the outermost epithelial layers of the target site, e.g., the 
mucosa of the uRT or the mucosal membrane of the eyes. 
While minimal cell damage can be repaired by removal 
of damaged organelles via cellular stress response path-
ways or autophagy, more severe damage is associated with 
structural changes (e.g., swelling of the cell membrane). 
These changes can deteriorate further, resulting in necro-
sis or in the more controlled process of apoptosis. More 
severe levels of irritation might also be accompanied by 
inflammation.
like in many other areas of toxicology, Fig. 3a also dis-
plays the difference between acute and chronic effects (left 
to the right side of Fig. 3a) of volatile chemicals causing 
local effects on the mucous membranes of the uRT and 
the eyes. However, information about sensory irritation 
is often lacking within the context of toxicological risk 
assessment or is assessed in humans, e.g., in experimental 
exposure studies with human volunteers. Such studies are 
usually designed to derive a sensory NOAec (initial start-
ing point of the first pathway) or lOAec and short-term 
exposures (2–4 h) to concentrations known to stimulate the 
chemosensory systems are investigated. In contrast, ani-
mal experiments can address adverse irritant or inflamma-
tory effects following acute, subacute, or chronic exposure 
toward high, cytotoxic concentrations. The effect assess-
ment is usually based on histological and pathological 
effects. Pure sensory effects can also be assessed in labora-
tory animals (e.g., Morris 2002), but such studies are very 
rare.
In conclusion, the proposed model assumes that (a) sen-
sory irritation occurs at lower concentrations than tissue 
irritation, (b) sustained exposure or high concentrations 
trigger a pathway-dependent response cascade, (c) certain 
steps lead to irreversible effects on both pathways, and (d) 
the two pathways become indistinguishable when morpho-
logically and biochemically ascertainable changes occur.
Based on experimental inhalation studies in humans 
or animals, and sometimes even on epidemiological stud-
ies, risk assessors might be able to derive two kinds of 
NOAecs (Fig. 3b). Since human inhalation studies usu-
ally investigate effects associated with sensory irritation, 
lOecs and NOecs for the first pathway can be derived by 
statistical comparisons. After the evaluation of these stud-
ies by risk assessors, a sensory NOAechuman can be derived 
(see upper part of Fig. 3b). Inhalation exposure stud-
ies in rodents may provide tissue irritation lOAecs and 
NOAecs (second pathway) that can be used to establish an 
irritative NOAecanimal during the process of deriving Oels 
(see lower part of Fig. 3b).
Definition of the NOAECs
Sensory NOAEChuman is based on NOecs showing no 
statistical significant difference from a control condition 
in experimental, short-term exposure studies conducted 
with human volunteers. Such studies should investigate 
sensory irritation by using appropriate methods (see Doty 
et al. 2004). guidance for the evaluation of such chem-
osensory effects has been given in the proceeding of the 
“adversity workshop” held in cologne in 2005 (for edito-
rial, see van Thriel et al. 2006a). Accordingly, a sensory 
NOAechuman should be derived from reactions caused by 
trigeminal chemoreception and measured distortion free 
with physiological measures, e.g., eyeblink frequency or 
biochemical analysis of nasal lavage fluid. These physi-
ological responses are based on sensory-mediated defense 
mechanisms/reflexes and are not adverse end points per 
se. However, if these defense mechanisms/reflexes are 
elicited continuously under high and prolonged exposure, 
they can result in adverse health effects. In combination 
with psychometric ratings of subjectively perceived symp-
toms, intensity estimates of irritation or odor perception 
give valuable input to improve the decision-making pro-
cess for determining Oels. If only psychometric ratings 
are available, not only the statistical difference should be 
considered but also the magnitude of the effect. Since pro-
cesses of sensory adaptation or temporal summation usu-
ally take place during a period of approximately 2 h (e.g., 
cain et al. 1986; van Thriel et al. 2005), the exposure in 
such sensory NOAechuman studies should continue for at 
least 2 h. Shorter studies can be used if it has been demon-
strated that the effect reaches its steady state at an earlier 
time point. Since trigeminal chemoreception is subjected 
to temporal integration/summation (Wise et al. 2005, 
2006), the time course of psychometric ratings across the 
exposure period might be used to discriminate between 
odor effects (e.g., reported annoyance) and sensory irrita-
tion (e.g., ratings of eye irritation). The studies should be 
conducted according to principles in experimental research 
(i.e., control for confounders, sequence effects etc.), and 
the sample size should be sufficient to detect even medium 
and sometimes small effects (e.g., by using techniques of 
statistical power analysis; Faul et al. 2007). As a rule of 
thumb, experiments investigating the response of volun-
teers to three or more exposure conditions are more sensi-
tive. In this case, smaller sample sizes might be sufficient 
(e.g., group size approximately ≥12 volunteers). epide-
miological studies conducted in the working environment 
might also provide a sensory NOAechuman if a clear asso-
ciation between measurements of exposure and sensory 
irritation exists.
According to this definition of the NOec, the lOec 
would be the first experimental condition (i.e., investigated 
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concentration) that statistically differs from the control con-
dition. considering the magnitude of the observed effect at 
this lOec and the biological mechanism underlying sen-
sory irritations, regulatory agencies might use either real 
NOecs or lOecs associated with weak effects to derive a 
“sensory NOAechuman.”
The irritative NOAecanimal is based on a statistically sig-
nificant NOAec found in chronic inhalation studies with 
rodents (2 years) by using biochemical and morphological 
examination techniques to identify even mild forms of tis-
sue irritation/damage in the uRT.
The evaluation of the proposed model suffers from a 
substantial lack of compounds for which sufficient human 
and animal data are available to establish an irritative 
NOAecanimal and a sensory NOAechuman. In the following 
section, selected compounds will be presented that might 
be feasible candidates for such an empirical underpinning 
of the proposed model. It will be checked whether ade-
quate human and animal data for indicating the two start-
ing points of the model has been gathered for these com-
pounds, and if so, whether rough estimates of the ratios 
between the two “effect thresholds” can be given. Previous 
assumptions underlying the existing default factors used in 
human risk assessment will be challenged.
Part 3: Recommendation for the derivation 
of occupational exposure limits based on sensory 
irritation on the URT and the mucous membranes 
of the eyes
general remarks
This part deals with the possibility to derive health-based 
occupational limit values for chemicals for which the most 
sensitive effect is sensory irritation of the uRT or the eyes. 
As such, these effects always start as acute irritation at the 
exposed site (eye, nose, and throat) but can—when exceed-
ing a certain concentration and exposure duration—also 
lead to cytotoxic and inflammatory effects.
It is noteworthy that if human data are available it is not 
used without considering animal data to form the full pic-
ture of the mode of actions and without taking into account 
the relevant effect thresholds seen in the animal data. The 
Oel setting process always requires a full review of all 
available toxicity databases on the substance in question. In 
a “case-by-case” approach, all relevant human, animal, and 
other experimental information as well as background data 
are assembled, and it is established which adverse effect(s) 
is(are) considered to be crucial for the setting of an Oel.
A substance can be considered to be a sensory irritant 
according to
(a) empirical results in humans (e.g., workplace exposure)
(b) physicochemical properties (e.g., pH value, reactivity) 
and structure–activity relationships
(c) animal inhalation studies
(d) animal irritation tests (eye, skin)
So far, only in vivo studies in animals and repeated expo-
sures allow deriving a NOAec for morphologically effects 
observable in the RT (irritative NOAecanimal). The results, 
however, do not exclude a sensory effect at lower concen-
trations. Sensory irritation of the eyes that might very well 
be more sensitive than the uRT cannot be reliably observed 
in animal inhalation studies, and the magnitude of irrita-
tion seen in eye irritation tests (e.g., Draize test) cannot be 
quantitatively extrapolated to humans. In controlled human 
studies, usually no histological examination of the uRT is 
possible but subjective and objective measures of sensory-
mediated reflexes of the uRT as well as eye irritation can 
be obtained (see Doty et al. 2004). Thus, animal and human 
studies complement each other on the effect continuum.
Oels can be set if
(a) Results from human exposure (controlled studies or 
workplace exposure) are available that allow a quan-
titative assessment. Ideally, human data have been 
obtained from experimental studies with controlled 
exposures and well-assessed end points of sensory-
mediated defense mechanisms/reflexes such as eye-
blink frequency. Though such studies are rarely 
available, they are an important basis for Oel set-
ting, especially in those cases where the sensory end 
point is more sensitive than the morphologic end 
point. Human data can also be obtained from occu-
pationally exposed persons. Such data may indeed be 
used for the derivation of Oels provided that at least 
some appropriate exposure measurements do exist. If 
good complete data from human exposure that allow 
the derivation of a NOAec or lOAec are not avail-
able, Oels should be evaluated on the basis of animal 
experiments. Human studies without controlled expo-
sure such as workplace studies typically can help to 
verify the animal data.
(b) Results from animal inhalation studies with repeated 
exposure are available which evaluated adequately 
local irritant effects. critical effects of an irritant are 
usually assessed based on histological signs of inflam-
mation or other end points, e.g., lesions of the respira-
tory or Oe, basal cell atrophy, hypertrophy of Bow-
man’s glands, or larynx metaplasia. In some cases, 
additional studies—in different species—may specifi-
cally address irritative end points such as nasal secre-
tion or mucociliary clearance.
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Inter‑/intraspecies extrapolation
In most cases, Oels are derived from NOAecs/lOAecs 
from animal studies with extrapolation factors (eF) to 
allow for inter- and intraspecies variability. Ideally, results 
from chronic animal studies are available; in other cases, 
time extrapolation may be necessary.
currently, for substances exerting systemic and local 
effects, the same eF, namely 1/5 for inter-/intraspecies 
(combined value) variability is used in the frame of the 
Oel and DNel concepts in case of inhalation toxicity 
data as a starting point. This factor was proposed to cover 
the variability of toxicokinetic and toxicodynamic aspects 
between humans and also potential additional interspecies 
variability. It is, however, only based on limited evidence. 
eceTOc proposed an interspecies factor of 1 and an 
intraspecies factor of 1/3 for local effects (eceTOc 2003, 
2010). In case that the Oe is the target tissue within the 
uRT, an interspecies extrapolation factor of 2 can be con-
sidered on a case-by-case basis. This consideration is based 
on the twofold higher airflow along the rat Oe resulting in 
a twofold high tissue burden in rats as compared to human 
Oe.
In the following, the magnitude of the extrapolation fac-
tor used for inter-/intraspecies variability (ieF) is evalu-
ated by using examples of chemicals for which animal 
and human data on local effects could be obtained from 
the literature. Instead of trying to determine the variabil-
ity between species and between human subjects, another 
approach was taken and the chronic N(O)Aec of the ani-
mal study for histology of the uRT was compared with the 
human NOAec for sensory irritation. An ieF was deduced 
from this comparison.
In the case of the human NOAec, it has to be borne in 
mind that this concentration is not a no-effect-concentra-
tion, i.e., the subjects may report sensory effects at this con-
centration but the magnitude of the response is judged to be 
not adversely affecting the person. even if the increase in 
the response compared to the control exposure is statisti-
cally significant, the magnitude of the increase is too low to 
be judged as adverse.
Exposure duration: time extrapolation
The european ReAcH framework has introduced so-called 
DNels (derived no effect levels). For derivation, default 
factors to be used when no chronic studies are available are
•	 1:6 for extrapolation from a subacute NOAec,
•	 1:2 for extrapolation from a subchronic NOAec.
In case of similar NOAecs observed in subacute and 
subchronic studies, the default factor for extrapolation from 
subchronic studies is not applied, because in that case the 
concentration plays a more important role than the duration 
for the development of adverse effects.
These factors are based on the literature evaluations and 
represent the geometric means of ratios of NOAecs for 
subacute, subchronic, and chronic animal studies. ece-
TOc (2003, 2010) has questioned the magnitude of these 
factors and proposed not using a teF for locally acting sub-
stances, because there are some examples where no lower-
ing of the NOAec with increasing exposure time can be 
seen in animal experiments (notably formaldehyde).
In contrast, the human sensory NOAecs/lOAecs are 
based on the stimulation of the chemosensory systems (see 
Part 1), often as acute inhalation study and they are sup-
posed to provide estimates of reversible effects located at 
very early stages of the first pathway of the model (feeling 
of the exposure). Such early and pure sensory responses do 
not appear to be associated with any cross talk between the 
nervous and the immune system (chiu et al. 2012) leading 
to non-sensory responses (e.g., release of cytokines). Based 
on some empirical evidence provided by experimental and 
epidemiological studies, initial indicators of sensory irri-
tation do not add up over time, at least not in subeffective 
concentrations. Thus, additional time extrapolation might 
not be required if Oels are derived from human sensory 
NOAecs.
This assumption can be verified by comparing NOAecs 
of acute human exposures with exposures at the workplace, 
although the number of compounds that allow for such a 
comparison is limited.
For methyl methacrylate, a NOAec of 40 ppm has 
been deduced from workplace data. The lOAec has been 
reported to be >100 ppm (Röhm 1994 in DFg 2006). The 
acute human experimental NOAec is 50 ppm (Table 2). 
Thus, in humans, acute and chronic NOAec are the same.
For calcium oxide, workplace data have shown a 
NOAec at an average concentration of 1.2 mg/m3 (0.4–
5.8 mg/m3) (Torén et al. 1996) which is in agreement with 
the experimental acute human NOAec of 1 mg/m3 (cain 
et al. 2004, 2008).
For disodiumtetraborate, workplace data (Hu et al. 1992; 
Wegman et al. 1994) show that exposure concentrations 
from 1.76 to 7 mg/m3 have a probability of 1 % to result 
in moderate or stronger nasal irritation (most sensitive tar-
get site). For the next higher exposure group 8.8–15.8 mg/
m3, the probability was 8 %. The concentration range up 
to 7 mg/m3 can therefore be interpreted as a NOAec. The 
human experimental acute NOAec is 5 mg/m3 (cain et al. 
2004, 2008). Thus, acute and chronic NOAec are quite 
similar.
From this albeit limited information, it can be deduced 
that the human acute experimental NOAec is similar to 
NOAecs derived from exposures at the workplace.




Substances were included which are under discussion in 
the MAK commission or in the uA III of the AgS due 
to unresolved questions regarding inter- and intraspecies 
variability and time extrapolation. As a result of this dis-
cussion, which included a literature search, 19 substances 
were identified known to be human irritants for which both 
human and animal data are available. However, these sub-
stances differed with respect to amount and quality of the 
database.
The available data were reviewed considering the fol-
lowing questions:
1. Is the sensory irritation effect the most sensitive end 
point?
2. Are data about morphologically and biochemically 
ascertainable changes from animal studies available 
and is the study quality sufficient?
Which NOAec and lOAec were found for subacute, 
subchronic, and chronic studies?
3. Are data about sensory irritation from animal studies 
available?
The evaluation started with those three substances for 
which a good complete database—human as well as ani-
mal—is available: for ethyl acrylate, formaldehyde, and 
methyl methacrylate, an appropriate chronic animal study 
and a controlled human exposure study of at least 2 h are 
available and allow the quantitative assessment of sen-
sory effects. The consideration of only substances with 
chronic animal studies in these cases avoids the necessity 
of time extrapolation. The ratio between lO(A)ecs and 
N(O)Aecs of the animal and human studies was calculated 
to deduce an overall ieF (Table 2). It should be pointed out 
that the concentration spacing used in the studies influences 
this ratio markedly.
For the following substances, the NOAecs and 
lOAecs of the studies cited were taken from the respec-
tive documentation(s) of MAK values, except for studies 
which are included in the list of references.
Ethyl acrylate From a chronic inhalation study (6 h/
day, 5 days/week, up to 27 months), a NOAec of 5 ppm 
and a lOAec of 25 ppm were derived based on non-
neoplastic changes at the Oe, hyperplasia, and inflamma-
tion of the Bowman’s glands in rats and mice (Miller et al. 
1985). The alterations in the nasal mucosa were present in 
subgroups of rats and mice at the first interim evaluation 
after 3 months of exposure for rats and after 6 months for 
mice. There were no exposure-related changes in the nasal 
mucosa of animals exposed to 5 ppm. The results of an 
experimental human study showed significantly increased 
eyeblink frequencies (about 30 %) at peak concentrations 
of 10 ppm (0–10 ppm, i.e., 5 ppm time-weighted average 
exposure concentrations (CTWA). Analysis of nasal lavage 
gave a slight but not significant indication of neurogenic 
inflammation. After constant exposure to 5 ppm, substance 
P was increased threefold, and changes in eyeblink fre-
quency were observed as well; therefore, 5 ppm were con-
sidered as lOAec, and after varying exposure to 2.5 ppm 
CTWA (0.5–5 ppm), a weak increase of 1.5 times was found, 
but not considered relevant. exposure to 2.5 ppm and above 
led to severe odor annoyance (Blaszkewicz et al. 2010).
The ratio of the chronic animal NOAec and the acute 
human NOAec gives a factor of 2.
Formaldehyde Formaldehyde has well been studied in 
animals and humans. Investigations on irritation effects in 
mice and rats show that mice (RD50: 3–5 ppm) are more 
sensitive compared to rats (RD50: 10–30 ppm). From 
chronic inhalation studies in rats, NOAecs of 1 ppm 
(Woutersen et al. 1989) and 2 ppm (Monticello et al. 1996) 
could be derived. In a chronic inhalation study in mice and 
Table 2  Results of the comparison for three substances with chronic inhalation studies in laboratory animals and human data from experimental 
studies
a
 According to the definition of sensory NOAechuman and irritative NOAecanimal. For some compounds, new data might be available that was 
not consider for Oel setting procedures yet (see “Substance” sections)
Substances lOAec (ppm)
NOAec (ppm)a for histology of uRT in animals




SA: subacute Sc: subchronic c: chronic
ethyl acrylate – 25 25 5 2 (5/2.5)
– 5 2.5
Formaldehyde 6 3 2 0.5 3.3 (1/0.3)
2 2 1 0.3
Methyl methacrylate 110 – 100 >100 0.6 (25/40)
– 25 40
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rats, effects were observed at all exposure levels (0, 2.0, 5.6, 
and 14.3 ppm, 6 h/day, 5 days/week, 24 months): rhinitis, 
epithelial dysplasia, and squamous metaplasia (Kerns et al. 
1983). Therefore, here a lOAec of 2 ppm is taken into 
consideration. The true NAec is expected to be between 1 
and 2 ppm. For this evaluation, a NOAec of 1 ppm is taken 
into account. In subchronic studies, a NOAec of 2 ppm can 
be derived from the study from Wilmer et al. (1989). The 
studies from Rusch et al. (1983) and Zwart et al. (1988) 
have found epithelial hyperplasia and metaplasia occurring 
already at a concentration of 3 ppm, the lOAec for effects 
from subchronic studies. NOAec and lOAec for subacute 
exposures can be taken from the study of Monticello et al. 
(1991) who found epithelial hyperplasia and metaplasia at 
a concentration of 6 ppm, while at 2 ppm no effects could 
be observed. The human NOAecs are between 0.3 ppm 
(with peaks of 0.6 ppm) (Paustenbach et al. 1997; lang 
et al. 2008) and 0.7 ppm (Müller et al. 2013). Since there 
are some indications for slight irritative effects at concen-
trations of 0.5–0.6 ppm, 0.3 ppm is considered as NOAec 
and 0.5 ppm as lOAec. The NOAecanimal and the NOAe-
chuman ratio results in a factor of 3.3.
As mentioned earlier, new data are available for this 
compound but have not been evaluated for setting Oels.
Methyl methacrylate An animal NOAec from a chronic 
inhalation study in rats (6 h/day, 5 days/week, 24 months) 
was set at 25 ppm. concentrations at and above 100 ppm 
caused degeneration, atrophy, hyperplasia, and metapla-
sia in the Oe, and hyperplasia and inflammation in the 
respiratory epithelium (eu 2002; lomax et al. 1997). In 
a study with subacute exposures (Hext et al. 2001) from 1 
to 28 days, toxicity at the Oe was observed at concentra-
tions of 110 and 400 ppm. However, effects after exposure 
to 110 ppm were fully reversible already during the expo-
sure period. Since there is no clear explanation for this 
phenomenon, 110 ppm cannot be regarded as a distinct 
NOAec.
A study in exposed workers, which involved determi-
nation of sensory irritation symptoms and rhinoscopy, 
revealed a NOAec of 40 ppm (Röhm 1994 in DFg 2006). 
Symptoms of irritation were reported at concentrations 
above 100 ppm. This is in agreement with recent experi-
mental human studies that found only weak irritation 
effects and moderate odor effects at concentrations up 
to 50 ppm (CTWA) (Muttray et al. 2007; van Thriel et al. 
2010). These effects were limited to reports of irritation 
since none of the applied physiological measures (e.g., 
eyeblink frequency) showed a significant increase at this 
concentration.
The ratio of the chronic animal NOAec and the acute 
human NOAec is 0.6.
This rather low ratio of animal NOAec/human NOAec 
might be due to the lower activity of carboxylesterases 
in human nasal tissues that would suggest that humans 
receive a lower dose of the cleavage product methacrylic 
acid, which is responsible for the irritation effects (see Part 
1). Additionally, the dose spacing in the animal study may 
have confounded the ratio.
Table 3  Application of an ieF of 3 to a data set with good quality but without chronic exposure study in animals
SA subacute, SC subchronic, C chronic
a
 According to the definition of sensory NOAechuman and irritative NOAecanimal. For some compounds, new data might be available that were 
not consider for Oel setting procedures yet (see “Substance” sections)
b
 With teF = 1 because in the subchronic study, effects were already seen after 4 days of exposure to 150 ppm
c
 With teF = 2, although subacute and subchronic study yielded the same NOAec, however, there was no lOAec obtained in either study
Substances Human lO(A)ec (ppm) 
and NO(A)ec (ppm)a
Application of interspecies 
factor (ieF) 3 to human 
NO(A)ec (ppm)
Application of time 
extrapolation factor (teF)
lOAec (ppm)
NOAec (ppm)a for histology of uRT in 
animals
SA: subacute Sc: subchronic
Acetaldehyde – 50 × 3 = 150 teF: 1 (Sc → c)b 243 150
150 × 1 = 150 150 5050
Ammonia – 25 × 3 = 75 teF: 2 (Sc → c) – 250
25 75 × 2 = 150 – 200
n-Butyl acetate – 147 × 3 = 441 teF: 2 (Sc → c) – 1,500
147 441 × 2 = 882 – 500
2-ethylhexanol 20 15 × 3 = 45 teF: 2 (Sc → c)c – –
15 45 × 2 = 90 120 120
Hydrogen sulfide – 5 × 3 = 15 teF: 2 (Sc → c) 80 30
5 15 × 2 = 30 30 (3 h/day) = 10 (8 h/
day)
10
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In conclusion, the ratios between the tissue irritation 
NOAecanimal and the sensory irritation NOAechuman are 
given in Table 2 range from 0.6 to 3.3 and accordingly, a 
default interspecies extrapolation factor (ieF) of “3” is 
proposed.
In the following section, the validity of this ieF of 3 will 
be evaluated for compounds with good but partly incom-
plete data, i.e., such compounds for which an appropriate 
subacute or subchronic but no chronic animal study are 
available. Our calculations are based on the NOAecs from 
the human data (sensory NOAechuman) shown in Table 3 
which are then multiplied by the ieF of 3. For compounds 
with no chronic animal study, it is necessary to extrapolate 
the chronic NOAec. Applying the default factors for time 
extrapolation (teF), theoretical values for the NOAecs for 
subchronic and subacute animal studies are calculated. The 
resulting product corresponds to the theoretical NOAec for 
a chronic animal study. The resulting theoretical NOAecs 
for subchronic or subacute animal studies are compared 
with the real data derived from toxicological studies.
Before getting to final conclusions about the applica-
bility of the ieF, the five substances fitting our definition 
of a substance with good but partly incomplete data are 
evaluated.
Acetaldehyde A human NOAec of 50 ppm was pro-
vided by a controlled acute study that did neither find self-
reported irritation nor measurable inflammatory effects. 
The following parameter were investigated: mucociliary 
transport time before and after exposure, interleukin-1β and 
interleukin 8 in nasal secretions, as well as mRNA-levels 
of interleukins-1β, 6 and 8, tumor necrosis factor-α, gran-
ulocyte-macrophage colony-stimulating factor, monocyte 
chemotactic protein 1, and cyclooxygenases 1 and 2 in 
nasal epithelial cells were measured after exposure (Mut-
tray et al. 2009).
A subchronic toxicity study in rats (Dorman et al. 
2008) with interim examinations showed that effects were 
observed already at day 4; therefore, there is no need to 
include time extrapolation in the calculation.
 Interspecies extrapolation for sensory irritation effects 
with the ieF of 3 [as the effects were seen in the Oe, a 
reduced ieF would be more appropriate to account for 
the lower burden in human Oe (see also Teeguarden et al. 
2008) and time extrapolation of 1] leads to an estimate 
of a subacute or subchronic NOAec of 150 ppm. This is 
comparable with the NOAec of 150 ppm found in a suba-
cute repeated dose-study (6 h/day, 5 days/week, 4 weeks) 
in rats, based on histopathological findings in the Oe, in 
particular loss of microvilli, thinning and disarrangement 
(Appelman et al. 1986), whereas 150 ppm was a lOAec 
in a subchronic study (6 h/day, 5 days/week, 13 weeks) in 
rats based on minimal olfactory degeneration at 150 ppm 
(NOAec 50 ppm). Mild inflammation and hyperplasia 
of the respiratory epithelium started at 500 ppm (Dorman 
et al. 2008). Based on the concentration of acetaldehyde in 
the Oe and taking into account AlDH2 polymorphisms in 
humans, the NOAec of 50 ppm found in the subchronic 
study with rats corresponds to a human equivalent concen-
tration of 67 ppm (Teeguarden et al. 2008). This calculation 
shows that using an ieF of 3 in the case of acetaldehyde 
would lead to a rather conservative Oel as compared to 
using a PBPK model.
Ammonia A human experimental study revealed 
increased symptom ratings and the perception of an 
unpleasant odor at 25 ppm but no objective signs of irrita-
tive effects (NOAec) (Sundblad et al. 2004). The applica-
tion of an ieF of 3 would give a concentration of 75 ppm. 
Additional adjustment for time extrapolation by application 
of a teF of 2 for subchronic effects results in a theoretical 
animal NOAec of 150 ppm. From an animal study with 
continuous exposure (24 h/day, 35–49 days) (Broderson 
et al. 1976), a NOAec of 200 ppm (lOAec 250 ppm) was 
derived in rats. This is in accordance with the theoretical 
NOAec derived from the human data although one needs 
to consider that the exposure regimen in the animal study 
(continuous exposure over 5–7 weeks) is quite unusual and 
creates some uncertainty.
According to recent studies (DFg 2000; Hoffmann et al. 
2004a, b; Ihrig et al. 2006) even at 50 ppm, strong irritation 
effects do not seem to occur.
n-Butyl acetate In a human experimental study, very 
slight irritative effects—according to the authors not to be 
considered as adverse—and the perception of an unpleas-
ant odor were reported at 147 ppm for 4 h (NOAec) and 
295 ppm for 20 min; higher concentrations were not tested 
(Iregren et al. 1993). Application of the ieF of 3 to the 
NOAec of the longest duration from this human study 
would lead to a NOAec of 441 ppm. Additional time 
extrapolation for a theoretical subchronic animal NOAec 
with a teF of 2 would lead to 882 ppm. From a subchronic 
inhalation study in rats (6 h/day, 5 days/week, 14 weeks), 
a NOAec of 500 ppm and a lOAec of 1,500 ppm were 
derived. Minimal to mild degeneration of the Oe along 
the dorsal medial meatus and ethmoturbinates of the nasal 
passages was seen at 1,500 ppm and more pronounced at 
3,000 ppm (David et al. 1998, 2001). Since the dosage 
in the rat inhalation study covered the range from 500 to 
1,500 ppm as lOAec, the “real” concentration with-
out effect NAec can be regarded as consistent with the 
882 ppm derived from the corresponding human study.
2-Ethylhexanol A controlled human study that found 
moderate to strong odor intensity and increased sub-
stance P in nasal lavage, indicating neurogenic inflamma-
tion, resulted in a human lOAec of 20 ppm (van Thriel 
et al. 2007). Based on the calculation of a benchmark 
dose analysis for eyeblink frequency, a human NOAec of 
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15 ppm was estimated (DFg 2012). Application of an ieF 
of 3 would give a theoretical NOAec for a chronic animal 
study of 45 ppm. Time extrapolation would lead to theo-
retical NOAecs of 90 ppm for a subchronic and 270 ppm 
for a subacute animal study. In a subacute (6 h/day, 5 days/
week, 2 weeks) and a subchronic (6 h/day, 5 days/week, 
12 weeks) animal study, the highest concentration tested 
was 120 ppm (BASF 1992). No adverse effects were 
found at this concentration, so that 120 ppm was defined 
as NOAec. A lOAec was not obtained. Therefore, dose 
response relation had not been fully elaborated, and with 
this limitation, this comparison includes some uncertain-
ties. Nevertheless, if combined with an ieF of 3 the results 
still appear to be compatible with the value derived from 
the human study.
Hydrogen sulfide A controlled human study which 
included ratings of acute symptoms and various aspects of 
chemosensory perception, postural sway, contrast sensitiv-
ity, and cognitive performance yielded a human NOAec 
of 5 ppm (Fiedler et al. 2008). An ieF of 3 would give a 
concentration of 15 ppm. As the daily exposure duration 
in the subacute study was only 3 h/day, an adjustment via 
the time-concentration product is necessary to extrapolate 
a NOAec for 8/day. Thus, a subacute NAec of 10 ppm 
was calculated which is the same as the NOAec of the 
subchronic study, and therefore, time extrapolation is not 
necessary (Oel Documentation “hydrogen sulfide,” TRgS 
900, http://www.baua.de/de/Themen-von-A-Z/gefahrst
offe/TRgS/pdf/900/900-schwefelwasserstoff.pdf?__blo
b=publicationFile&v=2). This would lead to theoreti-
cal NOAec of 15 ppm for a subchronic and 15 ppm for a 
subacute animal study. However, the real NOAec from the 
subchronic study is 10 ppm and the lOAec 30 ppm for 
effects in the Oe of rats (Brenneman et al. 2000; Dorman 
et al. 2004). The application of an ieF of 3 is therefore in 
line with the experimental results in animals. Moreover, a 
reduction in the default factor of 3 is warranted in that case, 
because the target tissue is Oe and there are modeling data 
on the extraction of hydrogen sulfide in the nose of rats and 
humans (Oel Documentation “hydrogen sulfide,” TRgS 
900, http://www.baua.de/de/Themen-von-A-Z/gefahrstoff
e/TRgS/pdf/900/900-schwefelwasserstoff.pdf?_blob=pub
licationFile&v=2). These data predict that the subchronic 
NOAec of 10 ppm corresponds to 21 ppm for humans.
In conclusion, the comparisons of the theoretical 
NOAecs derived from human data with application of 
the ieF of 3 with the available data from subacute and 
subchronic animal studies demonstrate that under condi-
tions of standard teFs, no significant discrepancies for four 
of the five compounds. Only in the case of 2-ethylhexanol 
would the human NOAec (15 ppm) be slightly overpre-
dicted (theoretical human NOAec 20 ppm) with the appli-
cation of an ieF of 3 to the animal data.
The default ieF“3” was also evaluated for the group of 
compounds with lower data density:
n-Butyl amine A controlled human study is lacking, and 
the human NOAec of 2 ppm from exposed workers is 
not well documented (Beard and Noe 1981). An ieF of 3 
would arrive at a concentration of 6 ppm. This would lead 
to a theoretical NOAec of 108 ppm for a theoretical suba-
cute lOAec from an animal study (1/3 NOAec/lOAec; 
1/6 subacute to chronic). Actually a lOAec of 17 ppm was 
found in a subacute study in rats (14 days) (BASF 2001).
Chlorine The human NOAec of 0.5 ppm is based on 
experimental studies (e.g., Rotman et al. 1983; Schins 
et al. 2000) which indicated no significant changes in lung 
function or signs of inflammation effects in the nose up to 
this concentration. An ieF of 3 leads to 1.5 ppm for the 
NOAec from a theoretical chronic animal study and to a 
lOAec of 4.5 ppm.
A chronic lOAec of 0.4 ppm was derived from a 
chronic inhalation study in rats and mice (6 h/day, 5 days/
week, 24 months), which revealed hypertrophy of goblet 
cells in rats and hyperplasia in the respiratory epithelium in 
mice at this dosage (Wolf et al. 1995).
Methyl acetate No irritation in volunteers of a toxicoki-
netic study exposed twice/day for 2 h each was reported 
up to 200 ppm methyl acetate. A lOAec was not avail-
able (Tada et al. 1974). Five minutes of exposure toward 
325 ppm methyl acetate were tolerated (NOAec), whereas 
4,050 ppm (lOAec) irritated trachea and throat (Flury 
and Wirth 1933). This study did not meet the inclusion 
criteria of at least 2 h of exposure. The theoretical suba-
cute NOAec starting from the NOAec of 200 ppm would 
be 3,600 ppm (ieF 3, teF 6). From a subacute inhalation 
study in the rat (6 h/day, 5 days/week, 28 days), no effects 
were seen at the lowest dose of 350 ppm (NOAec) and 
degeneration and necrosis of the Oe at 2,000 ppm (cela-
nese 1999).
Vinyl acetate A controlled human study is not avail-
able but a human NOAec of 10 ppm (lOAec 22 ppm) 
was based on insufficiently documented observational 
data (Deese and Joyner 1969). Application of the extrapo-
lation factor 3 for interspecies extrapolation to the human 
NOAec results in 30 ppm. Though the quality of these 
data is poor, they are in quite good agreement with the 
NOAec of 50 ppm (lOAec 200 ppm) which was found 
in a chronic inhalation study (6 h/day, 5 days/week, 
24 months) in rats and mice. Adverse effects that were seen 
at and above the lOAec of 200 ppm were atrophy, regen-
erative processes, inflammation, and metaplasia in the Oe 
as well as basal cell hyperplasia (Bogdanffy et al. 1994).
Application of the default factor “3” to the group of 
compounds with lower data density does not necessarily 
arrive at values obtained experimentally. In turn, however, 
application of the ieF of 3 will definitely not underestimate 
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human risk. Thus, it can be concluded that the ieF of 3 can 
obviously be used generally as default factor.
During the assessment process, it became clear that the 
remaining seven compounds dimethyl sulfoxide, dipro-
pylene glycol, glycerol, methoxyacetic acid, 4-methyl-3-
penten-2-on, pentanol isomers, trimethylamine did not meet 
the criteria for consideration in this paper. For example, in 
the case of methoxyacetic acid, systemic effects are more 
sensitive. glycerol is another example in which irrita-
tion was observed but not as the most sensitive end point. 
Results from animal studies with glycerol show that direct 
application to the animal eye results only in a very slightly 
irritating effect. A chronic local effect at a different location 
outside the uRT (squamous cell metaplasia at the epiglottis) 
was considered the most sensitive end point (DFg 2006).
Conclusions
comparison of human data with data from subacute and 
subchronic animal studies for those compounds with the 
most complete database lead us to conclude that an ieF 
of 3 is the most reasonable factor for extrapolating animal 
data concerning local irritating effects.
This was confirmed by the application of this factor to 
additional compounds with lower data density. Thus, we 
propose that an ieF of 3 should be applied for extrapola-
tion from animal data for all those substances with indica-
tion of local irritating effects as the most sensitive response 
(“leading health effect”) in animal studies but without reli-
able human data; unless individual data argue against this 
approach. In such cases, a substance-specific approach 
should be applied (Fig. 4). The example of hydrogen sulfide 
shows how substance-specific data on dosimetric species 
differences can be used to refine the risk assessment.
In case the target structure in the animal experiment is 
the Oe, it should be considered to reduce the default ieF 
to 2 because modeling of the airways of rats and humans 
have shown that in humans the fraction of the inhaled air 
reaching the Oe is only half of that in rats (Frederick et al. 
1998).
Due to the intense and ongoing discussion about how 
good human data can be generated to serve Oel setting 
in the context of sensory irritation (e.g., van Thriel et al. 
2006a), this idealized scheme might be applicable now 
and in the future. However, if only human studies of minor 
quality are available (see “Part 2: local effects of irritants 
on the upper respiratory tract and the mucous membranes 
of the eyes in the working environment—sensory and non-
sensory origins” section; definition of a sensory NOAe-
chuman), expert judgment is necessary to evaluate whether 
the flaws of the study preclude the derivation of a point of 
departure. guidance for this evaluation is given in several 
sections in this overview.
Interindividual differences in chemosensory-mediated 
effects
Regarding interindividual differences in humans, equiva-
lent to an intraspecies default factor, there are not many 
studies available that systematically investigated the role 
of such factors on chemosensory-mediated effects. Taking 
into account non-clinical differences (e.g., self-reported 
chemical sensitivity), interindividual differences might 
contribute little to chemosensory-mediated effects in a 
healthy population.
Various studies investigating lateralization thresholds 
(Dalton et al. 2000; van Thriel et al. 2006a) or other psy-
chophysical techniques (cometto-Muniz and cain 1990, 
1998) to estimate the trigeminal potency of a certain chem-
ical reported large interindividual differences in trigemi-
nal and olfactory sensitivity. Such information can hardly 
be used in the context of trigeminal-mediated defense 
mechanism that are the first adverse effects according to 
the model proposed in Fig. 3. In a series of experiments, 
the IfADo lab investigated the role of scS on different 
chemosensory effects [e.g., breathing frequency, eyeblink 
frequency (eBF), subjective ratings]. In these “sensitive” 
individuals, the breathing frequency was only slightly 
higher at the beginning of exposures to ethyl benzene or 
2-butanone, both applied in Oel concentrations (Haumann 
et al. 2003), but decreased during the 4-h exposure. How-
ever, in a second experiment investigating 2-propanol and 
1-octanol, these interindividual differences could not be 
observed. When evaluating chemosensory effects of acute 
exposures to 2-ethylhexanol (up to 40 ppm during expo-
sure peaks), scS and control subjects yielded comparable 
eyeblink frequencies (Kiesswetter et al. 2005). Only at the 
Fig. 4  An idealized scheme for the procedure suggested for setting 
an Oel from data regarding sensory irritation
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beginning of constant exposures to 1.5, 10, or 20 ppm, the 
scS subjects had higher eBFs. However, these interindi-
vidual differences were not exposure-related. When evalu-
ating the impact of scS on different psychometric ratings 
of the intensity of chemosensory perceptions or chem-
osensory-mediated health symptoms, only the latter were 
slightly increased in the scS group (van Thriel et al. 2005). 
Another group investigated the impact of cO2 sensitivity as 
a marker of trigeminal sensitivity in the context of experi-
mental exposures to formaldehyde (Mueller et al. 2013). 
No differences between hypo- and hypersensitive subjects 
were found for physiological measures of chemosensory-
mediated effects (e.g., eBFs) during various exposures 
to formaldehyde (including exposure peaks of 0.8 ppm). 
A more clinical population was investigated by Shuster-
man et al. (2005). Patients with seasonal allergic rhini-
tis (SAR) were exposed to acetic acid and their responses 
were compared to non-allergic control subjects (Shuster-
man et al. 2005). When challenged with 15 ppm acetic acid 
for 15 min, SAR subjects showed a significant increase in 
nasal airway resistance (NAR; measured by active pos-
terior rhinomanometry) than the control subjects. When 
normalized to baseline SAR subjects, NAR increased by 
22 % while those of the controls decreased by 11 %. In a 
previous study, the same group showed similar differences 
for SAR subjects when challenged with chlorine (Shus-
terman et al. 2003). Patients with sensory hyperreactivity 
(Millqvist et al. 2008) showed not only a higher number 
of coughs when provoked with 0.4 or 2 µM of capsaicin 
aerosols, their response was dose-dependent and increased 
by pre-inhalation of ethanol (5 and 25 %). control subjects 
showed no response to ethanol inhalation.
In conclusion, patients suffering from SAR, sensory 
hyperreactivity, or asthma (Roger et al. 1985) might show 
stronger chemosensory-mediated effects to local irritants 
than healthy controls. However, effects in asthmatics might 
be chemical dependent since ammonia did not provoke 
stronger effects in these patients (Petrova et al. 2008).
It is suggested that an intraspecies default factor is 
not necessary if Oels are derived from human sensory 
NOAecs since it is based on a controlled human exposure 
study assessing especially sensitive and objectively verifi-
able effects. Particularly, “sensitive” individuals can be 
considered by the choice of the adequate statistical meth-
ods. like for other toxicological end points, benchmark 
concentration levels (BMcls) might be derived to account 
for intraspecies differences. In toxicological risk assess-
ment, this approach was used for setting the Oel of 2-eth-
ylhexanol in the current MAK value documentation (DFg 
2012). More general, this approach was used for the evalu-
ation of acute SO2 effects on breathing depth in humans 
(Kleinbeck et al. 2011). Hence, the evaluation method 
always depends on study design and has to be selected 
accordingly. Moreover, human studies could include 
healthy volunteers, who were identified as “sensory sensi-
tive” with the help of specific tests (e.g., cO2 test, capsaicin 
test, scS questionnaire). So far, available data indicate that 
an intraspecies default factor >1 is not necessary whenever 
good experimental exposure studies with human volunteers 
are available.
A tentative Oel based on RD50 values
Some authors (e.g., Schaper 1993) proposed a conversion 
factor of 0.03 between the RD50 in mice, and a tentative 
Oel. This approach, which is quite schematic, does not 
take into account repeated dose toxicity and different bio-
logical mechanisms of different compounds. cytotoxic and 
tissue damaging effects for example are not well predicted 
by RD50 values (Bos et al. 2002). Therefore, RD50 value 
should be limited to an indicative tool for those compounds 
which might exert a sensory irritation below the thresh-
olds for observable morphological effects. The basis for 
the Oels used in this correlational approach might be (a) 
human exposure studies addressing chemosensory effects 
or (b) inhalational studies in animals measuring tissue irri-
tation and Oels should not be based solely on this value. 
It might be useful when comparing structurally similar 
compounds (e.g., aliphatic amines) with a common mode 
of action. Moreover, the detailed analysis of breathing pat-
terns in mice can provide valuable information to distin-
guish sensory irritation of the uRT from airflow obstruc-
tion/limitations and pulmonary irritation (e.g., Boylstein 
et al. 1996; Alarie 1998). Based on this approach, sub-
stances that might affect lRT without causing sensory irri-
tation can be identified.
Odor perception
Assessment of adverse effects occurring from odor must be 
dealt separately from irritation. This is due to the fact that 
such effects are only observed directly in humans. Further, 
it is unclear whether interindividual variability factors need 
to be considered for these compounds as their adversity 
occurs on a very individual level.
It is worth noting that OSHA has regulated three chemi-
cals based on adverse odor effects: isopropyl ether, phenyl 
ether, and vinyl toluene (OSHA 1989). These limit values 
were set based on worker complaints and the assumption 
that these substances can cause distraction effects creating 
safety hazards (van Thriel et al. 2003).
even though it is still difficult to assess the adversity of 
odor effects at least, they should be taken into account as 
additional information. For instance, odor perception is a 
warning signal and adaptation itself could be considered 
an adverse effect in situations where irritation is severe and 
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a substance’s odor may warn of the substance’s presence 
before irritating effects occur (Paustenbach and gaffney 
2005).
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